These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18025365)

  • 1. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
    Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
    Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
    Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
    Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A mutations in multiple primary melanomas.
    Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
    N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocortin-1 receptor: loss of function mutations and skin cancer.
    Mumm CD; Draznin M
    Dermatol Online J; 2006 Sep; 12(5):13. PubMed ID: 16962028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
    Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
    Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CDKN2A locus in patients with multiple primary melanomas.
    Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
    J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
    Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
    Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
    Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
    J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
    Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
    Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A as a uveal and cutaneous melanoma susceptibility gene.
    Kannengiesser C; Avril MF; Spatz A; Laud K; Lenoir GM; Bressac-de-Paillerets B
    Genes Chromosomes Cancer; 2003 Nov; 38(3):265-8. PubMed ID: 14506702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
    J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient.
    Sinnya S; Jagirdar K; De'Ambrosis B; McMeniman E; Sturm RA; Soyer HP
    Arch Dermatol Res; 2015 Oct; 307(8):741-5. PubMed ID: 26103950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
    Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
    Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
    Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
    Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.